Source:http://linkedlifedata.com/resource/pubmed/id/19641037
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-10-30
|
pubmed:abstractText |
Lymphocyte trafficking is a multistep, intricate process and involves a number of host factors such as integrins and chemokine receptors on lymphocytes, adhesion molecules on endothelial cells, and chemokines present in the local microenvironment. Previous studies have shown that HIV-1 Nef inhibits T cell chemotaxis in response to the physiological ligand SDF-1alpha [( 1) ]. In this study, we aimed to gain a better understanding of the inhibitory mechanisms and to define the molecular determinants of HIV-1 Nef for this phenotype. We showed that HIV-1 Nef inhibited transwell and transendothelial migration of T cells. Specifically, HIV-1 Nef protein impaired T cell chemotaxis toward SDF-1alpha without altering CXCR4 expression. Moreover, we showed that HIV-1 Nef protein down-modulated LFA-1 expression on T lymphocytes and diminished adhesion and polarization of T lymphocytes and as a result, led to decreased migration across the endothelium. Furthermore, we showed that the myristoylation site and DeltaSD domain played important roles in Nef-mediated inhibition of transwell and transendothelial migration and polarization of T lymphocytes; however, different sites or domains were needed for Nef-mediated LFA-1 down-modulation and impaired adhesion of T lymphocyte. Taken together, these results demonstrated that HIV-1 Nef inhibited T lymphocyte migration at multiple steps and suggest that membrane localization and intracellular signaling events likely contribute to the inhibitory effects of Nef on T cell migration and subsequently, the pathobiology of the HIV-1 Nef protein.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1938-3673
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
86
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1171-8
|
pubmed:meshHeading |
pubmed-meshheading:19641037-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:19641037-Cell Movement,
pubmed-meshheading:19641037-Chemotaxis, Leukocyte,
pubmed-meshheading:19641037-DNA Primers,
pubmed-meshheading:19641037-Endothelium, Vascular,
pubmed-meshheading:19641037-Flow Cytometry,
pubmed-meshheading:19641037-Gene Amplification,
pubmed-meshheading:19641037-Genes, Reporter,
pubmed-meshheading:19641037-HIV-1,
pubmed-meshheading:19641037-Humans,
pubmed-meshheading:19641037-Jurkat Cells,
pubmed-meshheading:19641037-Mutation,
pubmed-meshheading:19641037-Restriction Mapping,
pubmed-meshheading:19641037-Signal Transduction,
pubmed-meshheading:19641037-T-Lymphocytes,
pubmed-meshheading:19641037-nef Gene Products, Human Immunodeficiency Virus
|
pubmed:year |
2009
|
pubmed:articleTitle |
HIV-1 Nef-mediated inhibition of T cell migration and its molecular determinants.
|
pubmed:affiliation |
Center for AIDS Research and Department of Microbiology and Immunology, Indiana University School of Medicine, R2 302, 950 W. Walnut St., Indianapolis, IN 46202, USA. parki@iupui.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|